David Katz Bristol Myers Squibb CO Transaction History
Matrix Asset Advisors Inc
- $835 Million
- Q1 2024
A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 5,549 shares of BMY stock, worth $230,449. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,549
Previous 5,440
2.0%
Holding current value
$230,449
Previous $279,000
7.53%
% of portfolio
0.04%
Previous 0.04%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.73 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.75 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.8 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.69 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.92 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $88.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...